Reneo Pharmaceuticals

-$0.36 (-2.69%) As of 7:05 PM UTC today

Why Robinhood?

You can buy or sell RPHM and other stocks, options, and ETFs commission-free!

About RPHM

Reneo Pharmaceuticals, Inc. Common Stock, also called Reneo Pharmaceuticals, is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases.

CEO
Gregory J. Flesher
Employees
23
Headquarters
San Diego, California
Founded
2014

RPHM Key Statistics

Market Cap
312.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
112.65K
High Today
$13.75
Low Today
$12.92
Open Price
$13.16
Volume
16.22K
52 Week High
$17.18
52 Week Low
$11.63

You May Also Like

TYD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure